FBXO34 activators are diverse in nature, influencing the protein's activity through a myriad of cellular mechanisms. Compounds that increase intracellular cAMP levels trigger downstream phosphorylation events orchestrated by protein kinase A, which can enhance the activity of FBXO34, likely through direct phosphorylation or alteration of its binding to substrates. Similarly, activators of protein kinase C instigate phosphorylation cascades that may impinge upon FBXO34, potentially by modifying its conformation or its substrate recognition capabilities. These phosphorylation events can be further influenced by inhibitors of phosphatases, which maintain proteins in a phosphorylated state, thus potentially upregulating FBXO34 activity. Additionally, calcium ionophores raise intracellular calcium concentrations, activating calcium-dependent kinases that could act upon FBXO34, either directly or through complex calcium-dependent signaling networks.
On another front, the chemical inhibition of proteasome function leads to the stabilization of intracellular proteins, including FBXO34, thereby heightening its functional presence within the cell. The inhibition of specific kinases involved in cell cycle control may also result in the upregulation of FBXO34, as the altered cell cycle dynamics can affect a multitude of regulatory proteins. Cellular protectants against oxidative stress and compounds that maintain redox homeostasis ensure that FBXO34 remains in a reduced and active form, ready to engage with its partners. Polyamines and other small molecules that influence protein conformation and stability could also result in a more active FBXO34, by preserving its structure and enhancing its interactions with other proteins.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylyl cyclase, increasing intracellular cAMP levels, which can enhance the activity of FBXO34 via PKA-mediated phosphorylation processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C, which could phosphorylate substrates leading to the activation of FBXO34 in pathways where PKC-mediated signaling is involved. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $94.00 $259.00 | 2 | |
Increases intracellular calcium levels, which may activate calcium-dependent kinases that subsequently enhance the activity of FBXO34. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β, potentially leading to the stabilization and activation of FBXO34 through the prevention of GSK-3β-mediated phosphorylation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Proteasome inhibitor that could lead to the accumulation and increased activity of FBXO34 by preventing its proteasomal degradation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Antioxidant that could protect FBXO34 from oxidative stress-induced inactivation, thereby maintaining or enhancing its activity. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $56.00 $186.00 $296.00 $655.00 $2550.00 $3500.00 $10500.00 | 4 | |
Serves as a coenzyme in redox reactions, potentially enhancing the activity of FBXO34 by maintaining a favorable redox state for its activity. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $60.00 $192.00 $272.00 $883.00 | 1 | |
Polyamine that regulates cellular processes, which might stabilize FBXO34 conformation, thus promoting its activity in associated signaling pathways. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $45.00 $56.00 $183.00 | 142 | |
Inhibits tyrosine phosphatases, potentially leading to enhanced tyrosine phosphorylation and activation of FBXO34 or its substrates. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
Cyclin-dependent kinase inhibitor that could lead to the upregulation and activation of FBXO34 by altering cell cycle-related processes. | ||||||